International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Special Issue 6
Original Research Article
A Comparative Study between Silver Based Dressing and Vacuum Dressing in Management of Diabetic Foot Infection
Published
Feb. 27, 2024
Abstract

Background: Diabetic foot infections represent a significant healthcare challenge with considerable morbidity and economic burden. This study aimed to compare the efficacy of silver-based dressings and vacuum dressings in the management of diabetic foot infections. Methods: This prospective, randomized, comparative study enrolled 96 patients with diabetic foot infections (Wagner grade 2-3) who were randomized to receive either silver-based dressings (n=48) or vacuum dressings (n=48). The primary outcome was time to complete wound healing, with secondary outcomes including infection clearance, percentage reduction in wound area, time to granulation, pain scores, complications. Results: Complete wound healing at 12 weeks was achieved in 64.6% of the silverbased dressing group versus 81.3% of the vacuum dressing group (p=0.042). The median time to complete healing was significantly shorter with vacuum dressings (51.2 days vs. 68.5 days, p=0.008). The vacuum dressing group demonstrated superior outcomes in percentage reduction in wound area at 4 weeks (57.8% vs. 43.2%, p=0.001), 8 weeks (79.4% vs. 67.9%, p=0.003), and 12 weeks (92.7% vs. 81.5%, p=0.005), faster granulation tissue formation (17.6 vs. 24.3 days, p=0.007), and earlier infection clearance (12.7 vs. 15.2 days, p=0.042). The vacuum dressing group reported lower pain scores after week 1 (p<0.05) and higher satisfaction scores (p=0.014). Conclusion: Vacuum dressings demonstrated superior efficacy compared to silverbased dressings in the management of diabetic foot infections across multiple parameters including healing time, infection clearance, and patient comfort. These findings support the preferential use of vacuum dressings in the management of diabetic foot infections, particularly in moderate to severe cases.

Recommended Articles
Loading Image...
Volume-5, Special Issue 6
Citations
2518 Views
166 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved